Stacey Titus • June 28, 2023
HCMA Welcomes our newest Center of Excellence 
Stacey Titus

Allegheny Health Network HCM program is the HCMA’s newest Recognized Center of Excellence. AHN is a multi-disciplinary team of cardiovascular specialists trained in diagnosing and treating hypertrophic cardiomyopathy. The AHN team will provide patients with a comprehensive assessment and conduct a diagnostic test to determine the most appropriate therapy. Team members collaborate to provide patients with coordinated care, education, and support, including but not limited to heart failure specialists, cardiac surgeons, cardiac electrophysiologists, cardiac imagine specialists, interventional cardiologists, nurses, advanced practice providers, genetic counselors, dietitians rehabilitation specialists, high-risk obstetricians, and supportive care specialists. The HCM programs offer medical therapy, interventional therapy, such as alcohol septal ablation, and surgical therapy, such as septal myectomy. AHN also offers enrollment in clinical trials investigating new therapies for HCM. Program Director Pietro Bajona, MD, Ph.D. – Cardiac Surgeon trained at the Mayo Clinic and University of Toronto HCm programs and served as Surgical Director of the HCM Program at UTSW in Dallas, TX, before starting the HCM program at Allegheny General Hospital.

Program Director/Director of Cariac Surgery- Dr. Pietro Bajona

Co-Director/Advanced Heart Failure and Transplant- Dr. Craig Alpert

Cardiac Surgery – Dr. Stephen Bailey, MD

Interventional Cardiology – Dr. David Lasorda

Interventional Cardiology – Dr. Mithun Chavarthy

Advanced Cardiac Imaging (MRI) – Dr. Victor Farah

Advanced Cardiac Imaging (Echo) – Dr. Rachel Hughes-Doichev

Cardiac Electrophysiology – Dr. George Shaw

Pediatric Cardiology – Dr. Brian Feingold (UPMC Children’s Hospital of Pittsburgh)

Nursing Team –  Jennifer Keely, DNP, & Kathleen Ridgeway, RN

Genetic – Kyla Morphy

Pediatric Cardiology – Dr. Brian Feingold (UPMC Children’s Hospital of Pittsburgh)

Nutrition- Nonnie Toth

Gynecology & Family Planning – Dr. Diego Vasquez & Dr. Devon Ramaeker

Please visit for more information about Allegheny General Hosptial HCM Program –  Pittsburgh, PA please visit:  https://4hcm.org/directory/


For more information on all HCMA Recognized Centers of Excellence, please visit  https://4hcm.org/center-of-excellence/.

HCMA Blog

A light blue and dark blue paintbrush stroke intersect to make a stylized

Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)

By Erica Friedman • June 18, 2025
Alnylam press release on the European Commission approval of AMVUTTRA® (vutrisiran) forwild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM) as an additional indication
Light & dark blue brush stroke that intersect create an abstract letter 'a' next to the word Alnylam

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran) for Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)

By Erica Friedman • June 17, 2025
AMVUTTRA® (vutrisiran) has been approved by the U.S. Food and Drug Administration (FDA) to treat ATTR-CM in adults.
A pregnant woman and partner make a heart with their hands over the baby.

HCM in Pregnancy

By Sabrina Cuddy • June 12, 2025
Pregnancy is a stress on the body even for healthy people. When we have a serious disease, we tend to have even more questions. Health Educator Sabrina Cuddy answers some of the most common questions about HCM and Pregnancy.
More Posts